Type 1 Diabetes Mellitus (T1DM): Clinical Trials

20 trials for Type 1 Diabetes Mellitus (T1DM), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 recruiting, 6 completed, 3 not yet recruiting, 2 active not recruiting. 10 Not applicable, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable10Recruiting 6, Completed 2, Active not recruiting 1, Not yet recruiting 1
Phase 12Not yet recruiting 1, Terminated 1
Phase 32Completed 1, Not yet recruiting 1

Follow Type 1 Diabetes Mellitus (T1DM): new trials by email Literature Review of Type 1 Diabetes Mellitus (T1DM) trials Research Report on Type 1 Diabetes Mellitus (T1DM)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease Modification in Recent-Onset Type 1 Diabetes
Teplizumab, Intralymphatic Insulin Immunotherapy (ILIT) - Type 1 Diabetes Mellitus (T1DM), Type 1 Diabetes Mellitus
Phase 1Not yet recruitingAbdullah Kars602027-01-012026-05-27
GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes
GlycoQuest Digital Therapeutic, Enhanced Digital Psychoeducation - Type 1 Diabetes Mellitus (T1DM), Diabetes Distress
Not applicableRecruitingShifa International Hospital1102026-06-012026-07-24
Pediatric Insulin Plan Calculator for T1DM Management
Flexible Digital Insulin Dose Calculator - Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus (T1DM)
Not applicableRecruitingSultan Qaboos University4402026-05-032026-06-09
Drawing and Writing Activities in Adolescents With Type 1 Diabetes
Drawing and Writing Intervention - Type 1 Diabetes Mellitus (T1DM), Anxiety
Not applicableRecruitingGazi University502026-04-062026-09-21
Semaglutide Treatment in Type 1 Diabetes
Semaglutide 2.4mg, Semaglutide placebo - Obesity in Diabetes, Obesity/Therapy
Phase 3Not yet recruitingNordsjaellands Hospital1222025-10-012025-08-08
Thai PainPREDICT Validation Study
Thai PainPREDICT Questionnaire and Mobile Application - Painful Diabetic Neuropathy (PDN), Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation)
Not applicableRecruitingChulalongkorn University2772025-08-282025-10-03
Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes
Structured education program - Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus (T1DM)
Not applicableRecruitingDasman Diabetes Institute1282025-05-182025-05-22
Cardiovascular Risk in Children With Chronic Conditions Study
Kidney Transplant, Familial Hypercholesterolaemia
RecruitingSemmelweis University3002025-04-012025-08-08
The Effect of Hedia Diabetes Assistant on TiMe-in-range in People With Type 1 Diabetes and Sub-Optimal Glycemic Control in France - A Randomised Controlled Trial.
Hedia Diabetes Assistant - Type 1 Diabetes Mellitus (T1DM)
Not applicableActive not recruitingHedia ApS1542025-03-172026-04-09
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Libre 3 Plus Continuous Glucose Monitor, Dexcom G7 Continuous Glucose Monitor - Type 2 Diabetes Mellitus (T2DM), Type 1 Diabetes Mellitus (T1DM)
Not applicableRecruitingVanderbilt University Medical Center602025-03-092026-03-05
Comprehensive Intervention to Promote Adjustment in Adolescents With Type 1 Diabetes and Their Parents During Transfer of Health Care Responsibility
CONEXIÓN ADAPTAR - DM1, Usual Care - Type 1 Diabetes Mellitus (T1DM), Parent
Not applicableCompletedUniversidad de la Sabana342025-03-012026-10-21
Clinical Study: Analysis of Glycemic Control and Satisfaction With a Connected Smart Cap in Patients With Type 1 Diabetes Mellitus
CONNECTED SMART CAP - Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus (T1DM)
Not applicableCompletedFernando Sebastián Valles422025-02-262026-09-17
Psychological Factors and Self-Care Behaviors in Spanish Youth With Type 1 Diabetes: Age- and Sex-Based Comparisons and Associations
Psychological Distress, Eating Disorders
CompletedUniversity of Alicante1152025-02-172026-03-11
Motivational Interviewing and WhatsApp-Based Monitoring for Metabolic Control and Self-Efficacy in Adolescents With T1DM
Motivational interviewing, Social media-based patient monitoring - Type 1 Diabetes Mellitus (T1DM), Motivational Interviewing
Not applicableNot yet recruitingIstanbul Medeniyet University562024-10-152024-10-10
Environmental Determinants of Type 1 Diabetes Risk
Type 1 Diabetes Mellitus (T1DM), Healthy Control
RecruitingSecond Xiangya Hospital of Central South University112402024-08-012026-09-23
Digital Tracking With Auto Data Reporting
Type 1 Diabetes Mellitus (T1DM)
CompletedPersei Vivarium252024-07-222025-06-05
Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil
Tregopil - Type 1 Diabetes Mellitus (T1DM)
Phase 1TerminatedBiocon Limited552019-10-282022-06-27
Physical, Psychological and Socioeconomic Effects of Childhood Onset Diabetes in Sweden
Type 1 Diabetes Mellitus (T1DM), End-Stage Renal Disease
Active not recruitingUmeå University1150002019-05-082025-03-24
Prospective Cohort Study of Children Diagnosed with Type 1 Diabetes in Türkiye Between 2018 to 2022
Type 1 Diabetes Mellitus (T1DM)
CompletedTurkish Pediatric Diabetes Working Group27302018-01-012025-03-25
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
Sotagliflozin, Placebo - Type 1 Diabetes Mellitus (T1DM), High Level of Sugar (Glucose) in the Blood
Phase 3CompletedLexicon Pharmaceuticals14052015-09-012020-02-12

Narrower conditions

Diabetes Mellitus, Type 1 (20)  ·  Diabetes Mellitus, Type 2 (3)  ·  Obesity (2)  ·  Anxiety Disorders (1)  ·  Aortic Coarctation (1)  ·  Aortic Valve Stenosis (1)  ·  Diabetes Complications (1)  ·  Diabetic Neuropathies (1)  ·  Feeding and Eating Disorders (1)  ·  HIV Infections (1)  ·  Hyperglycemia (1)  ·  Hyperlipoproteinemia Type II (1)  ·  Hypertension (1)  ·  Hypertension, Pulmonary (1)  ·  Hypoglycemia (1)

Broader conditions

Autoimmune Diseases (20)  ·  Diabetes Mellitus (20)  ·  Endocrine System Diseases (20)  ·  Glucose Metabolism Disorders (20)  ·  Immune System Diseases (20)  ·  Metabolic Diseases (20)  ·  Nutritional and Metabolic Diseases (20)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (4)  ·  Body Weight (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)

Interventions

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1)  ·  Indium-105 (1)  ·  Motivational Interviewing (1)  ·  semaglutide (1)  ·  teplizumab (1)

Sponsors

Abdullah Kars (1)  ·  Biocon Limited (1)  ·  Chulalongkorn University (1)  ·  Dasman Diabetes Institute (1)  ·  Fernando Sebastián Valles (1)  ·  Gazi University (1)  ·  Hedia ApS (1)  ·  Istanbul Medeniyet University (1)  ·  Lexicon Pharmaceuticals (1)  ·  Nordsjaellands Hospital (1)  ·  Persei Vivarium (1)  ·  Second Xiangya Hospital of Central South University (1)  ·  Semmelweis University (1)  ·  Shifa International Hospital (1)  ·  Sultan Qaboos University (1)

Countries

Spain (4)  ·  Turkey (Türkiye) (4)  ·  Colombia (2)  ·  France (2)  ·  Germany (2)  ·  Hungary (2)  ·  Pakistan (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)

Top investigators

Ebaa Al Ozairi, MD (1)  ·  Jakkrit Amornvit, MD (1)  ·  Saima Abbass, MD, PhD (1)  ·  Sangeeta Sawhney, MD (1)  ·  Tamas Kiss, MD, PhD (1)  ·  Thomas F Dejgaard, MD, ph.d., endocrinologist (1)

Results publications

PMID 28899222, PMID 40211481, PMID 41634174

NIH funding

2019 (1)